Skip to content

Research on accurate prediction of liver metastasis in colon cancer patients based on multi-omics of circulating tumor cells and clusters derived from mesenteric venous system that drains in the portal vein of surgical specimens

Research on accurate prediction of liver metastasis in colon cancer patients based on multi-omics of circulating tumor cells and clusters derived from mesenteric venous system that drains in the portal vein of surgical specimens

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035524
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

Gold Standard:Clinical outcome
of&#32
tumor&#32
and&#32
clusters&#32
&#32
from&#32
mesenteric&#32
system&#32
drains&#32
in&#32
the&#32

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Between the ages of 19-80 years; (2) Able to comply with the requirements of the research and visit plan; (3) Volunteered to participate in this trial and signed informed consent; (4) Pathologically diagnosed as colon adenocarcinoma; (5) Clinical TNM staging is stage I, stage II, and stage III; (6) Patients who will undergo radical colonectomy.

Exclusion criteria

Exclusion criteria: (1) Patients who cannot complete radical resection of colon cancer; (2) Patients with liver disease; (3) Patients who need reconstruction or combined organ resection; (4) Patients with other malignant tumors or blood and immune system diseases; (5) Any anti-tumor treatment before tumor resection, including radiotherapy, chemotherapy, and molecular targeted therapy; (6) After the operation, it is found that the branch of the mesenteric vein of the specimen cannot be obtained due to severe infiltration or other reasons.

Design outcomes

Primary

MeasureTime frame
Genomics of Circulating Tumor Cell Genomics;liver metastasis;

Countries

China

Contacts

Public ContactJi-Yu Li

Shanghai Tenth People's Hospital

lijiyu@tongji.edu.cn+86 18918231588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026